<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="achon1b" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">achon1b</book-part-id>
      <title-group>
        <title>Achondrogenesis Type 1B</title>
        <alt-title alt-title-type="alt-title">Synonym: ACG1B</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Bonaf&#x000e9;</surname>
            <given-names>Luisa</given-names>
          </name>
          <xref ref-type="aff" rid="achon1b.AFF1"/>
          <degrees>MD, PhD</degrees>
          <email>luisa.bonafe@chuv.ch</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Mittaz-Crettol</surname>
            <given-names>Laur&#x000e9;ane</given-names>
          </name>
          <xref ref-type="aff" rid="achon1b.AFF2"/>
          <degrees>PhD</degrees>
          <email>Laureane.mittaz-crettol@chuv.ch</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Ballhausen</surname>
            <given-names>Diana</given-names>
          </name>
          <xref ref-type="aff" rid="achon1b.AFF3"/>
          <degrees>MD</degrees>
          <email>Diana.Ballhausen@chuv.ch</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Superti-Furga</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="achon1b.AFF4"/>
          <degrees>MD</degrees>
          <email>asuperti@unil.ch</email>
        </contrib>
      </contrib-group>
      <aff id="achon1b.AFF1">Associate Professor; Head, Division of Molecular Pediatrics<break/>Lausanne University Hospital<break/>Lausanne, Switzerland</aff>
      <aff id="achon1b.AFF2">Laboratory of Molecular Pediatrics<break/>Lausanne University Hospital<break/>Lausanne, Switzerland</aff>
      <aff id="achon1b.AFF3">Senior Lecturer, Division of Molecular Pediatrics<break/>Lausanne University Hospital<break/>Lausanne, Switzerland</aff>
      <aff id="achon1b.AFF4">Professor of Pediatrics, Department of Pediatrics<break/>Lausanne University Hospital<break/>Lausanne, Switzerland</aff>
      <pub-history>
        <date iso-8601-date="2002-08-30" date-type="created">
          <day>30</day>
          <month>08</month>
          <year>2002</year>
        </date>
        <date iso-8601-date="2013-11-14" date-type="updated">
          <day>14</day>
          <month>11</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="acp" document-type="chapter">Aceruloplasminemia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="achondroplasia" document-type="chapter">Achondroplasia</related-object>
      <abstract id="achon1b.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Clinical features of achondrogenesis type 1B (ACG1B) include extremely short limbs with short fingers and toes, hypoplasia of the thorax, protuberant abdomen, and hydropic fetal appearance caused by the abundance of soft tissue relative to the short skeleton. The face is flat, the neck is short, and the soft tissue of the neck may be thickened. Death occurs prenatally or shortly after birth.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of ACG1B rests on a combination of clinical, radiologic, and histopathologic features. <italic toggle="yes">SLC26A2</italic> (<italic toggle="yes">DTDST</italic>) is the only gene in which mutation is known to cause ACG1B.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Palliative care for liveborn neonates.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>ACG1B is inherited in an autosomal recessive manner. At conception, each sib of a proband with ACG1B has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if both disease-causing alleles in the family are known and the carrier status of the parents has been confirmed. Ultrasound examination after 14-15 weeks&#x02019; gestation can be diagnostic.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="achon1b.Diagnosis">
        <title>Diagnosis</title>
        <sec id="achon1b.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Achondrogenesis type 1B (ACG1B) is a perinatal lethal disorder with death occurring prenatally or shortly after birth. The diagnosis is usually established with the following:</p>
          <p>
            <bold>Clinical features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Extremely short limbs with short fingers and toes</p>
            </list-item>
            <list-item>
              <p>Hypoplasia of the thorax</p>
            </list-item>
            <list-item>
              <p>Protuberant abdomen</p>
            </list-item>
            <list-item>
              <p>Hydropic fetal appearance caused by the abundance of soft tissue relative to the short skeleton</p>
            </list-item>
            <list-item>
              <p>Flat face</p>
            </list-item>
            <list-item>
              <p>Short neck</p>
            </list-item>
            <list-item>
              <p>Thickened soft tissue of the neck</p>
            </list-item>
          </list>
          <p><bold>Radiographic findings.</bold> While the degree of ossification generally depends on gestational age, variability can be observed between radiographs taken at similar gestational ages; thus, no single feature should be considered obligatory:</p>
          <list list-type="bullet">
            <list-item>
              <p>Disproportion between the nearly normal-sized skull and very short body length. The skull may have a normal appearance or be mildly abnormal (reduced ossification for age; lateral or superior extension of the orbits; micrognathia).</p>
            </list-item>
            <list-item>
              <p>Total lack of ossification of the vertebral bodies or only rudimentary calcification of the center. The vertebral lateral pedicles are usually ossified.</p>
            </list-item>
            <list-item>
              <p>Short and slightly thin (but usually not fractured) ribs</p>
            </list-item>
            <list-item>
              <p>Iliac bone ossification limited to the upper part, giving a crescent-shaped, "paraglider-like" appearance on x-ray. The ischium is usually not ossified.</p>
            </list-item>
            <list-item>
              <p>Shortening of the tubular bones such that no major axis can be recognized. Metaphyseal spurring gives the appearance of a "thorn apple" or (for hematologic experts) "acanthocyte." The phalanges are poorly ossified and therefore are only rarely identified on x-ray.</p>
            </list-item>
            <list-item>
              <p>Only mildly abnormal clavicles (somewhat shortened but normally shaped and ossified) and scapulae (small with irregular contours) [<xref ref-type="bibr" rid="achon1b.REF.supertifurga.1996.957">Superti-Furga 1996</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="achon1b.Testing">
          <title>Testing</title>
          <p><bold>Histopathologic testing.</bold> In ACG1B, the histology of the cartilage shows a rarified cartilage matrix partially replaced by a larger number of cells. After hematoxylin-eosin staining, the matrix appears non-homogeneous with coarse collagen fibers. The fibers are denser around the chondrocytes, where they can form "collagen rings." After staining with cationic dyes (toluidine blue, alcian blue), which bind to the abundant polyanionic sulfated proteoglycans, normal cartilage matrix appears as a homogeneous deep blue or violet; in ACG1B, cartilage staining with these dyes is much less intense because of the defective sulfation of the proteoglycans.</p>
          <p><bold>Biochemical testing.</bold> The incorporation of sulfate into macromolecules can be studied in cultured chondrocytes and/or skin fibroblasts through double labeling with <sup>3</sup>H-glycine and <sup>35</sup>S-sodium sulfate. After incubation with these compounds and purification, the electrophoretic analysis of medium proteoglycans reveals a lack of sulfate incorporation [<xref ref-type="bibr" rid="achon1b.REF.supertifurga.1994.1137">Superti-Furga 1994</xref>] which can be observed even in total macromolecules. The determination of sulfate uptake is possible but cumbersome and is not used for diagnostic purposes [<xref ref-type="bibr" rid="achon1b.REF.supertifurga.1996b.100">Superti-Furga et al 1996b</xref>].</p>
          <sec id="achon1b.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">SLC26A2 (</italic>known previously as <italic toggle="yes">DTDST</italic>) is the only gene in which mutation is known to cause ACG1B [Superti-Furga 1996b].</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <table-wrap id="achon1b.T.summary_of_molecular_genetic_t" position="anchor" orientation="portrait">
              <label>Table 1.</label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Achondrogenesis Type 1B</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup>
</th>
                    <th id="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Mutations Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Mutation Detection Frequency by Test Method&#x000a0;<sup>3</sup>
</th>
                  </tr>
                  <tr>
                    <td headers="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_1" align="left" valign="middle" rowspan="3" colspan="1">
                      <italic toggle="yes">SLC26A2</italic>
                    </td>
                    <td headers="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Targeted mutation analysis</td>
                    <td headers="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Panel of selected mutations&#x000a0;<sup>4</sup>
</td>
                    <td headers="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">See footnote 5</td>
                  </tr>
                  <tr>
                    <td headers="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup>
</td>
                    <td headers="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">&#x0003e;90%&#x000a0;<sup>7</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                    <td headers="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">(Multi)exonic and whole-gene deletion/duplication</td>
                    <td headers="hd_b_achon1b.T.summary_of_molecular_genetic_t_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown, none reported</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="achon1b.TF.1">
                  <label>1.</label>
                  <p>See <related-object source-id="gene" document-id="achon1b" object-id="achon1b.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="achon1b.TF.1.1">
                  <label>2.</label>
                  <p>See <xref ref-type="sec" rid="achon1b.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants. </p>
                </fn>
                <fn id="achon1b.TF.1.2">
                  <label>3.</label>
                  <p>% of disease alleles detected in individuals with typical clinical, radiologic, and histologic features of ACG1B</p>
                </fn>
                <fn id="achon1b.TF.1.3">
                  <label>4.</label>
                  <p>Mutation panel may vary by laboratory.</p>
                </fn>
                <fn id="achon1b.TF.1.4">
                  <label>5.</label>
                  <p>Dependent on mutation panel and population tested. The four most common <italic toggle="yes">SLC26A2</italic> mutations (<xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">p.Arg279Trp</xref>, <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">c.-26+2T&#x0003e;C</xref> (IVS1+2T&#x0003e;C), <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">p.Arg178Ter</xref>, and <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">p.Cys653Ser</xref>) account for approximately 70% of disease alleles in all <italic toggle="yes">SLC26A2</italic>-related dysplasias, but only 10% of disease alleles in ACG1B.</p>
                </fn>
                <fn id="achon1b.TF.1.5">
                  <label>6.</label>
                  <p>Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="achon1b.TF.1.6">
                  <label>7.</label>
                  <p>90% of alleles in individuals with radiologic and histologic features compatible with the diagnosis of sulfate transporter-related dysplasias [<xref ref-type="bibr" rid="achon1b.REF.rossi.2001.159">Rossi &#x00026; Superti-Furga 2001</xref>]</p>
                </fn>
                <fn id="achon1b.TF.1.7">
                  <label>8.</label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="achon1b.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The diagnosis is first suspected on the basis of clinical and radiologic findings. Note: It is often difficult to distinguish between the three different forms of achondrogenesis: ACG1A, ACG1B, and ACG2 (see <xref ref-type="sec" rid="achon1b.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
            </list-item>
            <list-item>
              <p>Histopathology of cartilage is recommended as the second diagnostic step. </p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing is the preferred diagnostic test in probands with a clinical, radiologic, and/or histopathologic diagnosis of ACG1B: it allows precise diagnosis in the great majority of cases:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Although targeted mutation analysis is available, recurrent mutations are found in only a small number of individuals with ACG1B; therefore, sequence analysis of the entire coding region may be considered a first-line molecular genetic test. </p>
                </list-item>
                <list-item>
                  <p>Parental DNA analysis for the mutations found in the proband is recommended to confirm segregation of the two alleles in both compound heterozygous and homozygous individuals.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Note: A biochemical test is usually not needed before molecular genetic testing. </p>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the disease-causing mutations in the family.</p>
          <p>Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the disease-causing mutations in the family.</p>
        </sec>
      </sec>
      <sec id="achon1b.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="achon1b.Natural_History">
          <title>Clinical Description</title>
          <p>Achondrogenesis type 1B (ACG1B), one of the most severe chondrodysplasias, is a perinatal lethal disorder with death occurring prenatally or shortly after birth. The mechanism of the prenatal death is unknown. In the viable newborn, death is secondary to respiratory failure and occurs shortly after birth.</p>
          <p>Fetuses with ACG1B often present in breech position. Pregnancy complications as a result of polyhydramnios may occur.</p>
          <p>Clinical features of ACG1B include extremely shortened limbs, inturning of the feet and toes (talipes equinovarus), and brachydactyly (short stubby fingers and toes). The thorax is narrow and the abdomen protuberant. Frequently, umbilical or inguinal herniae are present.</p>
        </sec>
        <sec id="achon1b.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Genotype-phenotype correlations indicate that the amount of residual activity of the sulfate transporter modulates the phenotype in this spectrum of disorders that extends from lethal ACG1B to mild recessive multiple epiphyseal dysplasia (EDM4). Homozygosity or compound heterozygosity for mutations predicting stop codons or structural mutations in transmembrane domains of the sulfate transporter are associated with ACG1B, while mutations located in extracellular loops, in the cytoplasmic tail of the protein, or in the regulatory 5'-flanking region of the gene result in less severe phenotypes [<xref ref-type="bibr" rid="achon1b.REF.supertifurga.1996c.144">Superti-Furga et al 1996c</xref>, <xref ref-type="bibr" rid="achon1b.REF.karniski.2001.1485">Karniski 2001</xref>].</p>
          <p>Mutation <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">p.Arg279Trp</xref> is the most common <italic toggle="yes">SLC26A2</italic> mutation outside Finland (45% of alleles); it results in the mild EDM4 phenotype when homozygous and mostly in the diastrophic dysplasia (DTD) and atelosteogenesis type 2 (AO2) phenotypes when in the compound heterozygous state.</p>
          <p>The mutation <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">p.Arg178Ter</xref> is the second-most common mutation (9% of alleles) and is associated with a more severe DTD phenotype or even the perinatal-lethal AO2 phenotype, particularly when combined in <italic toggle="yes">trans</italic> with the <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">p.Arg279Trp</xref> mutation. This mutation has also been found in some cases of more severe recessive multiple epiphyseal dysplasia (rMED) and of ACG1B, making it one of two mutations identified in all four <italic toggle="yes">SLC26A2</italic>-related dysplasias.</p>
          <p>Mutations <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">p.Cys653Ser</xref> and <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">c.-26+2T&#x0003e;C</xref> are the third most common mutations (8% of alleles for each). </p>
          <p>Mutation <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">p.Cys653Ser</xref> results in EDM4/rMED when homozygous and in EDM4/rMED or DTD when present in <italic toggle="yes">trans</italic> with other mutations.</p>
          <p>Mutation <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">c.-26+2T&#x0003e;C</xref> is sometimes referred to as the "Finnish" mutation, because it is much more frequent in Finland than in the remainder of the world population. It produces low levels of correctly spliced mRNA and results in DTD when homozygous. Mutation <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">c.-26+2T&#x0003e;C</xref> is the only other mutation that has been identified in all four <italic toggle="yes">SLC26A2</italic>-related dysplasias, in compound heterozygosity with mild (rMED and DTD) or severe (AO2 and ACG1B) alleles [Bonafe, unpublished results; <xref ref-type="bibr" rid="achon1b.REF.dwyer.2010.3043">Dwyer et al 2010</xref>].</p>
          <p>The same mutations found in the ACG1B phenotype can also be found in the milder phenotypes (AO2 and DTD) if the second allele is a relatively mild mutation. Indeed, missense mutations located outside the transmembrane domain of the sulfate transporter are often associated with a residual activity that can "rescue" the effect of a null allele [<xref ref-type="bibr" rid="achon1b.REF.rossi.2001.159">Rossi &#x00026; Superti-Furga 2001</xref>].</p>
        </sec>
        <sec id="achon1b.Penetrance">
          <title>Penetrance</title>
          <p>For pathogenic mutations in <italic toggle="yes">SLC26A2</italic>, penetrance is complete. </p>
        </sec>
        <sec id="achon1b.Nomenclature">
          <title>Nomenclature</title>
          <p>The term achondrogenesis (Greek for "not producing cartilage") was given by the pathologist Marco Fraccaro in 1952 to the condition observed in a stillborn with severe micromelia and marked histologic changes in cartilage. In 1939, Hans Grebe attributed the same name to the condition observed in two sisters with markedly short limbs and digits but normal trunk; this condition, although superficially similar to Fraccaro's achondrogenesis, became later known as Grebe chondrodysplasia or Grebe syndrome.</p>
          <p>Subsequently, the name achondrogenesis was used to characterize the most severe forms of human chondrodysplasia, invariably lethal before or shortly after birth. In the 1970s, the heterogeneity of achondrogenesis was recognized. Using a combination of radiologic and histologic criteria, achondrogenesis type I (also called Fraccaro-Houston-Harris type) and type II (called Langer-Saldino type) were distinguished.</p>
          <p>In the 1980s, a new classification of achondrogenesis (types I to IV) based on radiologic criteria was proposed; the classification did not prove helpful and was later abandoned.</p>
          <p>In the late 1980s it was shown that achondrogenesis type II was caused by mutation of the gene encoding collagen II.</p>
          <p><xref ref-type="bibr" rid="achon1b.REF.borochowitz.1988.23">Borochowitz et al [1988]</xref> provided convincing histologic criteria for the further subdivision of achondrogenesis type I into types IA and IB, which is still very useful for the differential diagnosis:</p>
          <list list-type="bullet">
            <list-item>
              <p>ACG1A corresponds to the former eponym Houston-Harris type, and is caused by mutation of <italic toggle="yes">TRIP11</italic> [<xref ref-type="bibr" rid="achon1b.REF.smits.2010.206">Smits et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>ACG1B corresponds to the Fraccaro type. The confirmation of ACG1B as a separate entity came with the demonstration of sulfate transporter mutations in this histologic type.</p>
            </list-item>
            <list-item>
              <p>ACG2 corresponds to the Langer-Saldino type.</p>
            </list-item>
          </list>
          <p>ACG1B is currently classified in the "sulfation disorders group" in the revised Nosology and Classification of Genetic Skeletal Disorders [<xref ref-type="bibr" rid="achon1b.REF.warman.2011.943">Warman et al 2011</xref>].</p>
        </sec>
        <sec id="achon1b.Prevalence">
          <title>Prevalence</title>
          <p>No data on the prevalence of ACG1B are available. </p>
        </sec>
      </sec>
      <sec id="achon1b.Genetically_Related_Allelic_Diso">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Three other phenotypes (all with an autosomal recessive mode of inheritance) are associated with mutation of <italic toggle="yes">SLC26A2</italic> (<italic toggle="yes">DTDST</italic>):</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ao2" document-type="chapter"><bold>Atelosteogenesis type 2</bold></related-object>
<bold>(AO2)</bold> is a neonatal-lethal chondrodysplasia with clinical and histologic characteristics that resemble those of diastrophic dysplasia [<xref ref-type="bibr" rid="achon1b.REF.hastbacka.1996.255">Hastbacka et al 1996</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="diastrophic-d" document-type="chapter"><bold>Diastrophic dysplasia</bold></related-object>
<bold>(DTD)</bold> is a skeletal dysplasia characterized by short stature, joint contractures, cleft palate, and characteristic clinical signs such as the "hitchhiker" thumb and cystic swelling of external ears. The first mutations in <italic toggle="yes">SLC26A2</italic> were found in individuals with DTD [<xref ref-type="bibr" rid="achon1b.REF.hastbacka.1994.1073">Hastbacka et al 1994</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="edm" document-type="chapter"><bold>Recessive multiple epiphyseal dysplasia</bold></related-object>
<bold>(EDM4)</bold> is characterized by joint pain (usually in the hips and knees); deformities of the hands, feet, and knees; and scoliosis. Approximately 50% of affected individuals have an abnormal finding at birth (e.g., clubfoot, cleft palate, or cystic ear swelling). Median height in adulthood is at the tenth centile [<xref ref-type="bibr" rid="achon1b.REF.supertifurga.1996c.144">Superti-Furga et al 1996c</xref>, <xref ref-type="bibr" rid="achon1b.REF.supertifurga.1999.621">Superti-Furga et al 1999</xref>, <xref ref-type="bibr" rid="achon1b.REF.supertifurga.2001.282">Superti-Furga et al 2001</xref>].</p>
          </list-item>
        </list>
      </sec>
      <sec id="achon1b.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Achondrogenesis type 1B (ACG1B) should be distinguished from other lethal chondrodysplasias. As this is a large group of disorders, differentiation may be problematic.</p>
        <p>Making the correct diagnosis in fetuses with severe short-limbed chondrodysplasia by clinical and ultrasonographic findings alone is difficult. It is therefore important to obtain good radiographs, tissue for DNA extraction, skin biopsy for fibroblast culture, and bone and cartilage tissues for histology and biochemistry. The combination of radiologic and histologic findings gives a provisional diagnosis, which can then be confirmed by selected biochemical and/or molecular genetic investigations [<xref ref-type="bibr" rid="achon1b.REF.unger.2001.893">Unger et al 2001</xref>].</p>
        <p>Achondrogenesis is subtyped according to radiologic and histopathologic characteristics [<xref ref-type="bibr" rid="achon1b.REF.borochowitz.1988.23">Borochowitz et al 1988</xref>, <xref ref-type="bibr" rid="achon1b.REF.supertifurga.2001.282">Superti-Furga et al 2001</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p>Achondrogenesis type 1A (ACG1A; Houston-Harris type)</p>
          </list-item>
          <list-item>
            <p>ACG1B (Fraccaro type)</p>
          </list-item>
          <list-item>
            <p>Achondrogenesis type 2 (ACG2; Langer-Saldino type)</p>
          </list-item>
        </list>
        <p>Within the achondrogenesis group, clinical and radiologic distinction between ACG1A, ACG1B, and ACG2 is not always possible. The presence of rib fractures and the absence of ossification of vertebral pedicles may suggest ACG1A. The hands and fingers are markedly shortened in ACG1B and less so in ACG1A; they can be almost normal in ACG2. ACG2 shows more severe underossification of the vertebral bodies compared to ACG1B, in addition to quite typical configuration of the iliac bones with concave medial and inferior borders, and nonossification of the ischial and pubic bones.</p>
        <p>Histology of the cartilage is very useful in distinguishing the three different forms of achondrogenesis:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>ACG1A.</bold> The cartilage matrix is normal and inclusions are present in the chondrocytes.</p>
          </list-item>
          <list-item>
            <p><bold>ACG1B.</bold> The matrix is clearly abnormal (presence of "demasked," coarse collagen fibers, sometimes giving a wavy, sponge-like appearance) and has abnormal staining properties because of the reduced proteoglycans.</p>
          </list-item>
          <list-item>
            <p><bold>ACG2.</bold> The cartilage is hypervascular and hypercellular with reduced matrix and vacuoles ("Swiss cheese-like"), but has roughly normal staining properties.</p>
          </list-item>
        </list>
        <p>Features observed on histologic examination after staining with cationic dyes distinguish ACG1B from ACG1A, in which the matrix appears close to normal and chondrocytes show intracytoplasmic inclusions, and from ACG2, in which the matrix is rarified and vacuolated but stains normally and there are no "collagen rings." ACG2 also has inclusions.</p>
        <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/phenotypicSeries/PS200600">Achondrogenesis: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.</p>
        <p><bold>Other osteochondrodysplasias</bold> that are often in the differential diagnosis of ACG1B:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="oi" document-type="chapter"><bold>Osteogenesis imperfecta</bold></related-object>
<bold>types 2 and 3.</bold> Typical signs are soft undermineralized skull and blue sclerae; the bones are bowed but not as short as in achondrogenesis. Multiple fractures are present.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="td" document-type="chapter"><bold>Thanatophoric dysplasia</bold></related-object>. The limbs are longer than in ACG and the thorax is narrow but elongated. In thanatophoric dysplasia type II, cloverleaf skull is common.</p>
          </list-item>
          <list-item>
            <p><bold>Short rib-polydactyly syndromes.</bold> Polydactyly is usually present; when absent, the short rib-polydactyly syndromes may be confused with thanatophoric dysplasia.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="rbs" document-type="chapter"><bold>Roberts syndrome</bold></related-object>. Severe limb shortening with only mildly affected axial skeleton may suggest Roberts syndrome. In Roberts syndrome standard cytogenetic preparations stained with Giemsa or C-banding techniques show in most chromosomes during metaphase the characteristic chromosomal abnormality of premature centromere separation (PCS) and separation of the heterochromatic regions [also called heterochromatin repulsion (HR)]. Mutation of <italic toggle="yes">ESCO2</italic> is causative.</p>
          </list-item>
          <list-item>
            <p><bold>Fibrochondrogenesis.</bold> Distinguishing radiographic features of fibrochondrogenesis are marked metaphyseal flaring of the long bones and clefts of the vertebral bodies.</p>
          </list-item>
        </list>
      </sec>
      <sec id="achon1b.Management">
        <title>Management</title>
        <sec id="achon1b.Evaluations_Following_Initial_Di">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with achondrogenesis type 1B (ACG1B), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Complete skeletal survey</p>
            </list-item>
            <list-item>
              <p>Respiratory status</p>
            </list-item>
            <list-item>
              <p>Genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="achon1b.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Provide palliative care for viable newborns.</p>
        </sec>
        <sec id="achon1b.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="achon1b.Related_Genetic_Counseling_Issue">Related Genetic Counseling Issues</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="achon1b.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="achon1b.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="achon1b.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Achondrogenesis type 1B (ACG1B) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="achon1b.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes and therefore carry a single copy of a disease-causing mutation in <italic toggle="yes">SLC26A2</italic>. Note: Parental testing is always recommended when mutations are identified in a proband, in order to confirm the segregation of mutations in the family and confirm the carrier status of both parents. Results should always be discussed with the family in the context of a genetic counseling consultation.</p>
            </list-item>
            <list-item>
              <p>Heterozygous carriers are asymptomatic and have normal stature.</p>
            </list-item>
            <list-item>
              <p>No evidence suggests that carriers are at increased risk of developing degenerative joint disease.</p>
            </list-item>
            <list-item>
              <p>To date, <italic toggle="yes">de novo</italic> mutation in the proband and germline mosaicism in the parents have not been reported. </p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of a proband with ACG1B has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> ACG1B is a perinatal lethal condition; affected individuals do not reproduce.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="achon1b.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible if the disease-causing mutations in the family have been identified. </p>
          <p>Carrier detection in reproductive partners of a heterozygous individual is possible. The partners can be screened for the four most common pathogenic alleles: <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">p.Arg279Trp</xref>, <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">p.Cys653Ser</xref>, <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">p.Arg178Ter</xref>, and <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">c.-26+2T&#x0003e;C</xref>. When these four alleles are excluded, the risk of carrying a <italic toggle="yes">SLC26A2</italic> mutation is reduced from the general population risk of 1:100 to approximately 1:330.</p>
        </sec>
        <sec id="achon1b.Related_Genetic_Counseling_Issue">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Family planning</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers. </p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="achon1b.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>
            <bold>High-risk pregnancies</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Molecular genetic testing.</bold> Prenatal diagnosis for pregnancies at 25% risk is possible by analysis of DNA extracted from fetal cells obtained by chorionic villus sampling (CVS) at approximately ten to 12 weeks' gestation or by amniocentesis usually performed at approximately 15 to 18 weeks' gestation. Both disease-causing alleles of an affected family member must be identified before prenatal testing can be performed.Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
            </list-item>
            <list-item>
              <p><bold>Ultrasound examination.</bold> Transvaginal ultrasound examination early in pregnancy is a reasonable alternative to molecular prenatal diagnosis because the testing is not invasive. However, the diagnosis can be made with confidence only at week 14-15, and reliability is highly operator dependent.</p>
            </list-item>
            <list-item>
              <p><bold>Biochemical testing.</bold> No data on prenatal functional biochemical testing (sulfate incorporation test on chorionic villus or fibroblasts) are available.</p>
            </list-item>
          </list>
          <p>
            <bold>Low-risk pregnancies</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>One parent is heterozygous and the other parent does not have one of the four common mutations.</bold> Follow up of pregnancies by ultrasound is recommended [<xref ref-type="bibr" rid="achon1b.REF.canto.2007.976">Canto et al 2007</xref>, <xref ref-type="bibr" rid="achon1b.REF.schramm.2009.160">Schramm et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Routine ultrasound examination.</bold> Routine prenatal ultrasound examination may identify very short fetal limbs &#x000b1; polyhydramnios &#x000b1; small thorax and raise the possibility of achondrogenesis in a fetus not known to be at risk. Subtle ultrasound findings may be recognizable in the first trimester, but in low-risk pregnancies the diagnosis of a skeletal dysplasia is usually not made until the second trimester.</p>
            </list-item>
            <list-item>
              <p><bold>Molecular genetic testing.</bold> DNA extracted from cells obtained by amniocentesis can be theoretically analyzed to try to make a molecular diagnosis prenatally. However, the differential diagnosis in such a setting is very broad (see <xref ref-type="sec" rid="achon1b.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
            </list-item>
          </list>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the disease-causing mutations have been identified. </p>
        </sec>
      </sec>
      <sec id="achon1b.Resources">
        <title>Resources</title>
      </sec>
      <sec id="achon1b.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="achon1b.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Mutation of <italic toggle="yes">SLC26A2</italic> [<xref ref-type="bibr" rid="achon1b.REF.dawson.2005.385">Dawson &#x00026; Markovich 2005</xref>] is responsible for the family of chondrodysplasias including achondrogenesis 1B (ACG1B), <related-object link-type="booklink" source-id="gene" document-id="diastrophic-d" document-type="chapter">diastrophic dysplasia</related-object> (DTD), <related-object link-type="booklink" source-id="gene" document-id="ao2" document-type="chapter">atelosteogenesis type 2</related-object> (AO2), and <related-object link-type="booklink" source-id="gene" document-id="edm" document-type="chapter">recessive multiple epiphyseal dysplasia</related-object> (EDM4) (see <xref ref-type="sec" rid="achon1b.Genetically_Related_Allelic_Diso">Genetically Related Disorders</xref>) [<xref ref-type="bibr" rid="achon1b.REF.hastbacka.1996.255">Hastbacka et al 1996</xref>, <xref ref-type="bibr" rid="achon1b.REF.supertifurga.1996a.195">Superti-Furga et al 1996a</xref>, <xref ref-type="bibr" rid="achon1b.REF.supertifurga.1999.621">Superti-Furga et al 1999</xref>]. Impaired activity of the sulfate transporter in chondrocytes and fibroblasts results in the synthesis of proteoglycans that are not sulfated or are insufficiently sulfated [<xref ref-type="bibr" rid="achon1b.REF.rossi.1996a.18456">Rossi et al 1996a</xref>, <xref ref-type="bibr" rid="achon1b.REF.rossi.1998.361">Rossi et al 1998</xref>, <xref ref-type="bibr" rid="achon1b.REF.satoh.1998.12307">Satoh et al 1998</xref>], most likely because of intracellular sulfate depletion [<xref ref-type="bibr" rid="achon1b.REF.rossi.1996a.18456">Rossi et al 1996a</xref>]. Undersulfation of proteoglycans affects the composition of the extracellular matrix and leads to impairment of proteoglycan deposition, which is necessary for proper enchondral bone formation [<xref ref-type="bibr" rid="achon1b.REF.corsi.2001.1375">Corsi et al 2001</xref>, <xref ref-type="bibr" rid="achon1b.REF.forlino.2005.859">Forlino et al 2005</xref>]. A correlation exists between the mutation, the predicted residual activity of the sulfate transporter, and the severity of the phenotype [<xref ref-type="bibr" rid="achon1b.REF.cai.1998.58">Cai et al 1998</xref>, <xref ref-type="bibr" rid="achon1b.REF.rossi.2001.159">Rossi &#x00026; Superti-Furga 2001</xref>, <xref ref-type="bibr" rid="achon1b.REF.karniski.2004.2165">Karniski 2004</xref>, <xref ref-type="bibr" rid="achon1b.REF.maeda.2006.1143">Maeda et al 2006</xref>].</p>
          <p><bold>Gene structure.</bold> The coding sequence of <italic toggle="yes">SLC26A2</italic> is organized in two coding exons separated by an intron of approximately 1.8 kb. A further untranslated exon is located 5' relative to the two coding exons; it has probable regulatory functions, as the mutation c.-26+2T&#x0003e;C (the "Finnish" allele) located in this region was shown to lead to reduced mRNA transcription [<xref ref-type="bibr" rid="achon1b.REF.hastbacka.1999.664">Hastbacka et al 1999</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="achon1b" object-id="achon1b.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign allelic variants.</bold> See <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">Table 2</xref>. The p.Thr689Ser allele has been frequently observed at the heterozygous or homozygous state in several controls of different ethnicities and is very likely to be a normal allelic variant [<xref ref-type="bibr" rid="achon1b.REF.cai.1998.58">Cai et al 1998</xref>, <xref ref-type="bibr" rid="achon1b.REF.rossi.2001.159">Rossi &#x00026; Superti-Furga 2001</xref>]. </p>
          <p>There is evidence that p.Arg492Trp is a rare benign variant, found in seven out of 200 Finnish controls and in five out of 150 non-Finnish controls; in vitro expression of this variant showed normal sulfate transport activity [<xref ref-type="bibr" rid="achon1b.REF.bonafe.2008.827">Bonaf&#x000e9; et al 2008</xref>]. This allele was erroneously considered pathogenic in previous reports [<xref ref-type="bibr" rid="achon1b.REF.rossi.2001.159">Rossi &#x00026; Superti-Furga 2001</xref>].</p>
          <p><bold>Pathogenic allelic variants.</bold> See <xref ref-type="table" rid="achon1b.T.slc26a2_allelic_variants_discu">Table 2</xref>. Four pathogenic alleles of <italic toggle="yes">SLC26A2</italic> appear to be recurrent: p.Arg279Trp, p.Cys653Ser, p.Arg178Ter, and c.-26+2T&#x0003e;C. Together they represent approximately 70% of the pathogenic allelic variants in SLC26A2, however, most of these alleles are found in individuals with allelic disorders (see <xref ref-type="sec" rid="achon1b.Genetically_Related_Allelic_Diso">Genetically Related Disorders</xref>). These recurrent variants are rarely found in individuals with ACG1B.</p>
          <p>Two mutations, c.1751delA and p.Val341del, seem to be recurrent in ACG1B. Mutation c.1751delA has been found in seven out of 40 ACG1B-causing alleles and mutation p.Val341del has been found in nine out of 40 ACG1B-causing alleles; their frequency is however very low in other <italic toggle="yes">SLC26A2</italic>-related skeletal phenotypes. </p>
          <p>In compound heterozygotes, the phenotype associated with each pathogenic allele depends on the combination with the second mutation. Distinct phenotypes known to be allelic to ACG1B are <related-object link-type="booklink" source-id="gene" document-id="ao2" document-type="chapter">atelosteogenesis type 2</related-object> (AO2), <related-object link-type="booklink" source-id="gene" document-id="diastrophic-d" document-type="chapter">diastrophic dysplasia</related-object> (DTD), and recessive <related-object link-type="booklink" source-id="gene" document-id="edm" document-type="chapter">multiple epiphyseal dysplasia</related-object> (rMED). (For more information, see <related-object source-id="gene" document-id="achon1b" object-id="achon1b.molgen.TA">Table A</related-object>.)</p>
          <table-wrap id="achon1b.T.slc26a2_allelic_variants_discu" position="anchor" orientation="portrait">
            <label>Table 2.</label>
            <caption>
              <p><italic toggle="yes">SLC26A2</italic> Allelic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Class of Variant Allele</th>
                  <th id="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                  <th id="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
                <tr>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                    <bold>Benign</bold>
                  </td>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.835C&#x0003e;T</td>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Arg492Trp</td>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_4" align="left" valign="middle" rowspan="8" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_000112.3">NM_000112.3</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_000103.2">NP_000103.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.2065A&#x0003e;T</td>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Thr689Ser</td>
                </tr>
                <tr>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_1" align="left" valign="middle" rowspan="6" colspan="1">
                    <bold>Pathogenic</bold>
                  </td>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.-26+2T&#x0003e;C&#x000a0;<sup>2</sup><break/>(IVS1+2T&#x0003e;C)</td>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.532C&#x0003e;T</td>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Arg178Ter</td>
                </tr>
                <tr>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.835C&#x0003e;T</td>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Arg279Trp</td>
                </tr>
                <tr>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.1724delA&#x000a0;<sup>3</sup><break/>(1751delA)</td>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Lys575SerfsTer10</td>
                </tr>
                <tr>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.1020_1022del&#x000a0;<sup>3</sup></td>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Val341del</td>
                </tr>
                <tr>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.1957T&#x0003e;A</td>
                  <td headers="hd_b_achon1b.T.slc26a2_allelic_variants_discu_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Cys653Ser</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="achon1b.TF.2">
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
              </fn>
              <fn id="achon1b.TF.2.1">
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature. </p>
              </fn>
              <fn id="achon1b.TF.2.2">
                <p>Ter = termination codon</p>
              </fn>
              <fn id="achon1b.TF.2.3">
                <p>1. Variant designation that does not conform to current naming conventions</p>
              </fn>
              <fn id="achon1b.TF.2.4">
                <p>2. Frequent in the Finnish population, but also accounts for 7% of alleles in non-Finnish populations. See <xref ref-type="sec" rid="achon1b.GenotypePhenotype_Correlations">Genotype/Phenotype Correlations</xref>.</p>
              </fn>
              <fn id="achon1b.TF.2.5">
                <p>3. Recurrent mutations in individuals with ACG1B</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> The sulfate transporter gene <italic toggle="yes">SLC26A2</italic> encodes a protein of 739 amino acids that is predicted to have 12 transmembrane domains and a carboxy-terminal, cytoplasmic, moderately hydrophobic domain [<xref ref-type="bibr" rid="achon1b.REF.hastbacka.1994.1073">Hastbacka et al 1994</xref>]. This protein transports sulfate into chondrocytes to maintain adequate sulfation of proteoglycans. The sulfate transporter protein belongs to the family of sulfate permeases. The overall structure with 12 membrane-spanning domains is shared with two other human anion exchangers: PDS (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/274600">274600</ext-link>), a chloride-iodide transporter involved in <related-object link-type="booklink" source-id="gene" document-id="pendred" document-type="chapter">Pendred syndrome</related-object>; and CLD, which is responsible for congenital chloride diarrhea. The function of the carboxy-terminal hydrophobic domain of <italic toggle="yes">SLC26A2</italic> is not yet known. <italic toggle="yes">SLC26A2</italic> is expressed in developing cartilage in human fetuses but also in a wide variety of other tissues [<xref ref-type="bibr" rid="achon1b.REF.haila.2001.973">Haila et al 2001</xref>]. The size of the predominant mRNA species is larger than 8 kb, indicating the existence of significant untranslated sequences [<xref ref-type="bibr" rid="achon1b.REF.hastbacka.1999.664">Hastbacka et al 1999</xref>].</p>
          <p><bold>Abnormal gene product.</bold> Most of the <italic toggle="yes">SLC26A2</italic> mutations either predict a truncated polypeptide chain or change amino acids that are located in transmembrane domains or conserved in man, mouse, and rat. Individuals homozygous for the "Finnish" mutation c.-26+2T&#x0003e;C have reduced levels of mRNA with intact coding sequence [<xref ref-type="bibr" rid="achon1b.REF.rossi.1996b.657">Rossi et al 1996b</xref>]. Thus, the mutation presumably interferes with splicing and/or further mRNA processing and transport [<xref ref-type="bibr" rid="achon1b.REF.hastbacka.1996.255">Hastbacka et al 1996</xref>, <xref ref-type="bibr" rid="achon1b.REF.hastbacka.1999.664">Hastbacka et al 1999</xref>].</p>
          <p>ACG1B-associated mutations p.Arg178Ter, c.1724delA, and p.Val341del were shown to abolish or to drastically reduce sulfate transporter activity in a <italic toggle="yes">Xenopus</italic> oocyte model [<xref ref-type="bibr" rid="achon1b.REF.karniski.2001.1485">Karniski 2001</xref>], and in a HEK-293 cell culture model [<xref ref-type="bibr" rid="achon1b.REF.karniski.2004.2165">Karniski 2004</xref>], respectively.</p>
        </sec>
      </sec>
      <sec id="achon1b.References">
        <title>References</title>
        <sec id="achon1b.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="achon1b.Literature_Cited.reflist0">
            <ref id="achon1b.REF.bonafe.2008.827">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e4;stbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campos-Xavier</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiesa</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>A novel mutation in the sulfate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia.</article-title>
                <source>J Med Genet</source>
                <year>2008</year>
                <volume>45</volume>
                <fpage>827</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">18708426</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.borochowitz.1988.23">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Borochowitz</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adomian</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spear</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                </person-group>
                <article-title>Achondrogenesis type I: delineation of further heterogeneity and identification of two distinct subgroups.</article-title>
                <source>J Pediatr</source>
                <year>1988</year>
                <volume>112</volume>
                <fpage>23</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">3275766</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.cai.1998.58">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cai</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakayama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiraki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozono</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Mutational analysis of the DTDST gene in a fetus with achondrogenesis type 1B.</article-title>
                <source>Am J Med Genet</source>
                <year>1998</year>
                <volume>78</volume>
                <fpage>58</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">9637425</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.canto.2007.976">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Canto</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buixeda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palau</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ojeda</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Early ultrasonographic diagnosis of diastrophic dysplasia at 12 weeks of gestation in a fetus without previous family history.</article-title>
                <source>Prenat Diagn.</source>
                <year>2007</year>
                <volume>27</volume>
                <fpage>976</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17602446</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.corsi.2001.1375">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Corsi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riminucci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>LW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianco</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Achondrogenesis type IB: agenesis of cartilage interterritorial matrix as the link between gene defect and pathological skeletal phenotype.</article-title>
                <source>Arch Pathol Lab Med</source>
                <year>2001</year>
                <volume>125</volume>
                <fpage>1375</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11570921</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.dawson.2005.385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markovich</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Pathogenetics of the human SLC26 transporters.</article-title>
                <source>Curr Med Chem</source>
                <year>2005</year>
                <volume>12</volume>
                <fpage>385</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">15720248</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.dwyer.2010.3043">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dwyer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyland</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Modaff</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pauli</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>Genotype-phenotype correlation in DTDST dysplasias: Atelosteogenesis type II and diastrophic dysplasia variant in one family.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2010</year>
                <volume>152A</volume>
                <fpage>3043</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">21077202</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.forlino.2005.859">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piazza</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiveron</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Della Torre</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tatangelo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonafe</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gualeni</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pecora</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype.</article-title>
                <source>Hum Mol Genet</source>
                <year>2005</year>
                <volume>14</volume>
                <fpage>859</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">15703192</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.haila.2001.973">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haila</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hastbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohling</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karjalainen-Lindsberg</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kere</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saarialho-Kere</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <article-title>SLC26A2 (diastrophic dysplasia sulfate transporter) is expressed in developing and mature cartilage but also in other tissues and cell types.</article-title>
                <source>J Histochem Cytochem</source>
                <year>2001</year>
                <volume>49</volume>
                <fpage>973</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">11457925</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.hastbacka.1994.1073">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hastbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahtani</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clines</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reeve-Daly</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kusumi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trivedi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weaver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coloma</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovett</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buckler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaitila</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping.</article-title>
                <source>Cell</source>
                <year>1994</year>
                <volume>78</volume>
                <fpage>1073</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">7923357</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.hastbacka.1999.664">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hastbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerrebrock</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mokkala</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clines</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovett</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaitila</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>ES</given-names>
                  </name>
                </person-group>
                <article-title>Identification of the Finnish founder mutation for diastrophic dysplasia (DTD).</article-title>
                <source>Eur J Hum Genet</source>
                <year>1999</year>
                <volume>7</volume>
                <fpage>664</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">10482955</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.hastbacka.1996.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hastbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>ES</given-names>
                  </name>
                </person-group>
                <article-title>Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.</article-title>
                <source>Am J Hum Genet</source>
                <year>1996</year>
                <volume>58</volume>
                <fpage>255</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">8571951</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.karniski.2001.1485">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karniski</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype.</article-title>
                <source>Hum Mol Genet</source>
                <year>2001</year>
                <volume>10</volume>
                <fpage>1485</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">11448940</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.karniski.2004.2165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karniski</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <article-title>Functional expression and cellular distribution of diastrophic dysplasia sulfate transporter (DTDST) gene mutations in HEK cells.</article-title>
                <source>Hum Mol Genet</source>
                <year>2004</year>
                <volume>13</volume>
                <fpage>2165</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">15294877</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.maeda.2006.1143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maeda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyamoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karniski</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakashima</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikegawa</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>A compound heterozygote harboring novel and recurrent DTDST mutations with intermediate phenotype between atelosteogenesis type II and diastrophic dysplasia.</article-title>
                <source>Am J Med Genet A</source>
                <year>2006</year>
                <volume>140</volume>
                <fpage>1143</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16642506</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.rossi.1996a.18456">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaventure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delezoide</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for an L483P substitution in the diastrophic dysplasia sulfate transporter.</article-title>
                <source>J Biol Chem</source>
                <year>1996a</year>
                <volume>271</volume>
                <fpage>18456</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">8702490</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.rossi.1998.361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaitila</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production.</article-title>
                <source>Matrix Biol</source>
                <year>1998</year>
                <volume>17</volume>
                <fpage>361</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9822202</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.rossi.2001.159">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance.</article-title>
                <source>Hum Mutat</source>
                <year>2001</year>
                <volume>17</volume>
                <fpage>159</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">11241838</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.rossi.1996b.657">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Harten</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beemer</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gitzelmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia.</article-title>
                <source>Hum Genet</source>
                <year>1996b</year>
                <volume>98</volume>
                <fpage>657</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">8931695</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.satoh.1998.12307">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Satoh</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shukunami</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Negoro</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiraki</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Functional analysis of diastrophic dysplasia sulfate transporter. Its involvement in growth regulation of chondrocytes mediated by sulfated proteoglycans.</article-title>
                <source>J Biol Chem</source>
                <year>1998</year>
                <volume>273</volume>
                <fpage>12307</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">9575183</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.schramm.2009.160">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schramm</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloning</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minderer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daumer-Haas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;rtnagel</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nerlich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tutschek</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal sonographic diagnosis of skeletal dysplasias.</article-title>
                <source>Ultrasound Obstet Gynecol.</source>
                <year>2009</year>
                <volume>34</volume>
                <fpage>160</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">19548204</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.smits.2010.206">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smits</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolton</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funari</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyden</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manning</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dwyer</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moran</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prysak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merriman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikegawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krakow</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirchhausen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beier</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <article-title>Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210.</article-title>
                <source>N Engl J Med.</source>
                <year>2010</year>
                <volume>362</volume>
                <fpage>206</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">20089971</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.supertifurga.1994.1137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>A defect in the metabolic activation of sulfate in a patient with achondrogenesis type IB.</article-title>
                <source>Am J Hum Genet</source>
                <year>1994</year>
                <volume>55</volume>
                <fpage>1137</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">7977372</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.supertifurga.1996.957">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Achondrogenesis type 1B.</article-title>
                <source>J Med Genet</source>
                <year>1996</year>
                <volume>33</volume>
                <fpage>957</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">8950678</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.supertifurga.2001.282">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonafe</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                </person-group>
                <article-title>Molecular-pathogenetic classification of genetic disorders of the skeleton.</article-title>
                <source>Am J Med Genet</source>
                <year>2001</year>
                <volume>106</volume>
                <fpage>282</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">11891680</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.supertifurga.1996a.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hastbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Harten</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gitzelmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans.</article-title>
                <source>Ann N Y Acad Sci</source>
                <year>1996a</year>
                <volume>785</volume>
                <fpage>195</fpage>
                <lpage>201</lpage>
                <pub-id pub-id-type="pmid">8702127</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.supertifurga.1996b.100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hastbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Harten</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gitzelmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene.</article-title>
                <source>Nat Genet</source>
                <year>1996b</year>
                <volume>12</volume>
                <fpage>100</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">8528239</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.supertifurga.1999.621">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riebel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eich</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunze</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation.</article-title>
                <source>J Med Genet</source>
                <year>1999</year>
                <volume>36</volume>
                <fpage>621</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10465113</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.supertifurga.1996c.144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gitzelmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations.</article-title>
                <source>Am J Med Genet</source>
                <year>1996c</year>
                <volume>63</volume>
                <fpage>144</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8723100</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.unger.2001.893">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meinecke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitayat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>New dysplasia or achondrogenesis type 1B? The importance of histology and molecular biology in delineating skeletal dysplasias.</article-title>
                <source>Pediatr Radiol</source>
                <year>2001</year>
                <volume>31</volume>
                <fpage>893</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11727031</pub-id>
              </element-citation>
            </ref>
            <ref id="achon1b.REF.warman.2011.943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krakow</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeMerrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundlos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savarirayan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sillence</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Nosology and classification of genetic skeletal disorders: 2010 revision.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2011</year>
                <volume>155A</volume>
                <fpage>943</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">21438135</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="achon1b.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="achon1b.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>14 November 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>22 September 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>27 December 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>21 July 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>30 August 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>21 February 2002 (lb) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
